Evaluation of Peakmaster for computer-aided multivariate optimisation of a CE separation of 17 antipsychotic drugs using minimal experimental data

Electrophoresis

Volumn 30, Issue 5, 2009, Pages 839-847

  Johns, Kara F ^a   Breadmore, Michael C ^a   Bruno, Raimondo ^b   Haddad, Paul R ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Antipsychotics; Computer simulations; Modified chromatographic response function; Peakmaster; Selectivity optimization

Indexed keywords

CHROMATOGRAPHY;

ANALYTES; ANTIPSYCHOTIC; ANTIPSYCHOTIC DRUG; CHROMATOGRAPHIC RESPONSE FUNCTIONS; CONDITION; MODIFIED CHROMATOGRAPHIC RESPONSE FUNCTION; MULTIVARIATE OPTIMIZATION; OPTIMISATIONS; PEAKMASTER; SELECTIVITY OPTIMIZATION;

IONIC STRENGTH;

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PROCHLORPERAZINE MALEATE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHROMATOGRAPHY; COMPUTER ANALYSIS; COMPUTER PROGRAM; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG STRUCTURE; ELECTROPHORETIC MOBILITY; ION TRANSPORT; IONIC STRENGTH; PH MEASUREMENT; PROCESS OPTIMIZATION; SEPARATION TECHNIQUE;

EID: 65949120000     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200800532     Document Type: Article

References (30)

1. Thornman, W., Electrophoresis 1999, 20, 3202-3236.
2. Lukulay, P. H., McGuffin, V. L., J. Microcol. Sep. 1996, 8, 211.
3. Siouffi, A. M., Phan-Tan-Luu, R., J. Chromatogr. A 2000, 892, 75-106.
4. Jaroš , M., Vcelakova, K., Zuskova, I., Gaš , B., Electrophoresis 2002, 23, 2667-2677.
5. Gaš , B., Jaroš , M., Hruska, V., Zuskova, I., Stedry, M., Lc Gc Europe 2005, 18, 282.
6. Surowiec, I., Kaml, I., Kenndler, E., J. Chromatogr. A 2004, 1024, 245-254.
7. Jaroš , M., Soga, T., van de Goor, T., Gaš , B., Electrophoresis 2005, 26, 1948-1953.
8. Goncalves, L. C., Micke, G. A., J. Chromatogr. A 2007, 1154, 477-480.
9. Hirokawa, T., J. Chromatogr. 1983, 271, D1.
10. Tuma, P., Samcova, E., Opekar, F., Jurka, V., Stulik, K., Electrophoresis 2007, 28, 2174-2180.
11. Costa, A. C. O., Luiz da Costa, J., Tonin, F. G., Tavares, M. F. M., Micke, G. A., J. Chromatogr. A 2007, 1171, 140-143.
12. Thormann, W., Ther. Drug Monit. 2002, 24, 222-231.
13. Gross, A. S., J. Clin. Pharmacol. 2001, 52, 5S-10S.
14. Shenfield, G. M., J. Clin. Pharmacol. 2001, 52, 35-45.
15. Mitchell, P. B., J. Clin. Pharmacol. 2001, 52, 455-545.
16. Velligan, D. I., Lam, Y. F., Glahn, D. C., Barrett, J. A. et al., Schizophr. Bull. 2006, 32, 724-742.
17. Raggi, M. A., Bugamelli, F., Mandrioli, R., Sabbioni, C. et al., J. Chromatogr. A 2001, 916, 289-296.
18. Pucci, V., Raggi, M. A., Kenndler, E., J. Chromatogr. A 1999, 853, 461-468.
19. Izzo, G., Raggi, M. A., Maichel, B., Kenndler, E., J. Chromatogr. B 2001, 752, 47-53.
20. Hillaert, S., Snoeck, L., van den Bossche, W., J. Chromatogr. A 2004, 1033, 357-362.
21. Pucci, V., Raggi, M. A., Kenndler, E., J. Liq. Chromatogr. 2000, 23, 25-34.
22. Aumatell, A., Chem. Australia 1996, 63, 312-314.
23. Muijselaar, P., Claessens, H. A., Cramers, C. A., J. Chromatogr. A 1996, 735, 395-402.
24. Madej, K., Wozniakiewicz, M., Kala, M., Chromatographia 2005, 61, 259-263.
25. Baselt, R. C., Disposition of Toxic Drugs and Chemicals in Man, 6th Edn., Biomedical Publications, CA 2002.
26. Vcelakova, K., Zuskova, I., Kenndler, E., Gaš, B., Electrophoresis 2004, 25, 309-317.
27. Berridge, J. C., J. Chromatogr. 1982, 244, 1-14.
28. Momenbeik, F., Johns, C., Breadmore, M., Hilder, E. et al., Electrophoresis 2006, 27, 4039-4046.
29. Li, S. F. Y. Capillary Electrophoresis: Principles, Practice and Applications, Elsevier Science Publishers, The Netherlands 1992.
30. Mosher, R. A., Saville, D. S., Thormann, W., Weinheim, V. C. H., The Dynamics of Electrophoresis, Germany 1992.